Clinical Trial Update: Compassionate Use Ponatinib

View source ↗

Summary

This clinical trial update indicates that the compassionate-use program for ponatinib is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Leukemias

Drugs mentioned

• Ponatinib (Iclusig) (ponatinib)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Philadelphia Chromosome Positive (Ph+) Leukemias, Chronic Myeloid Leukemia | Status: NO_LONGER_AVAILABLE